Latest News
Conference Coverage
Unacceptable pain despite inflammation control commonly occurs in PsA patients
MADRID – The percentage with unacceptable pain despite inflammation control was twice as high for nonresponders versus responders to anti-TNF...
News
EULAR keeps csDMARDs as top PsA drugs
EULAR’s revised psoriatic arthritis recommendations retain methotrexate and other csDMARDS as first-line treatment over TNF inhibitors.
Conference Coverage
Infections linked with transition to psoriatic arthritis
In women, these associations included salmonella infection, sepsis, and uveitis; in men, they included gangrene, encephalitis, and hidradenitis...
Conference Coverage
Obesity might be targetable driver of psoriatic arthritis progression
MADRID – Two studies show how obesity correlates with greater psoriatic arthritis disease activity and disability and how substantial weight loss...
Conference Coverage
Ixekizumab surpasses adalimumab in PsA head-to-head study
MADRID –
News
Carotid ultrasound may aid cardiovascular risk stratification of patients with psoriatic disease
The study suggests that bedside ultrasound could be a valuable augmentation to traditional risk stratification in these patients.
News
Active psoriatic arthritis, ankylosing spondylitis linked to increase in adverse pregnancy outcomes
Women with psoriatic arthritis and ankylosing spondylitis generally have favorable pregnancy outcomes, but high disease activity during pregnancy...
News
Th17-associated cytokines, CRP fail as biomarkers for ustekinumab success in PsA
Baseline levels of IL-17A, IL-17F, IL-23, and C-reactive protein were not associated with response to ustekinumab in either skin or joints.
Latest News
EMA: Stop high-dose Xeljanz in certain patients
The temporary recommendation applies to all tofacitinib indications.
Conference Coverage
VA system lags in getting DMARDs to veterans with inflammatory arthritis
MADISON, WISC. – More than two-thirds of ankylosing spondylitis patients didn’t receive a DMARD in the first year...